Lipids in the nervous system: From biochemistry and molecular biology to patho-physiology

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 1, 2015, Pages 51-60

  Cermenati, Gaia ^a   Mitro, Nico ^a   Audano, Matteo ^a   Melcangi, Roberto C ^a   Crestani, Maurizio ^a   De Fabiani, Emma ^a   Caruso, Donatella ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Myelin lipids; Myelin proteins; Nervous system; Neuroprotection; Transgenic models

Indexed keywords

CERAMIDE; CHOLESTEROL DERIVATIVE; FATTY ACID DERIVATIVE; GLUCOSYLCERAMIDE; MYELIN PROTEIN; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN; SULFATIDE;

ARTICLE; CHOLESTEROL TRANSPORT; DISORDERS OF LIPID METABOLISM; GENETIC DISORDER; HUMAN; LIPIDOMICS; LIPOGENESIS; MOLECULAR BIOLOGY; NERVOUS SYSTEM; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN LIPID INTERACTION; TRANSGENIC ORGANISM; ANIMAL; LIPID METABOLISM; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; LIPID METABOLISM; NERVOUS SYSTEM;

EID: 84911874735     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.08.011     Document Type: Review

References (111)

1. G. Saher, B. Brugger, C. Lappe-Siefke, W. Mobius, R. Tozawa, M.C. Wehr, F. Wieland, S. Ishibashi, and K.A. Nave High cholesterol level is essential for myelin membrane growth Nat. Neurosci. 8 2005 468 475
2. B. Garbay, A.M. Heape, F. Sargueil, and C. Cassagne Myelin synthesis in the peripheral nervous system Prog. Neurobiol. 61 2000 267 304
3. G. Gopalakrishnan, A. Awasthi, W. Belkaid, O. De Faria Jr., D. Liazoghli, D.R. Colman, and A.S. Dhaunchak Lipidome and proteome map of myelin membranes J. Neurosci. Res. 91 2013 321 334
4. O. Maier, D. Hoekstra, and W. Baron Polarity development in oligodendrocytes: sorting and trafficking of myelin components J. Mol. Neurosci. 35 2008 35 53
5. C. Lohmann, E. Schachmann, T. Dandekar, C. Villmann, and C.M. Becker Developmental profiling by mass spectrometry of phosphocholine containing phospholipids in the rat nervous system reveals temporo-spatial gradients J. Neurochem. 114 2010 1119 1134
6. D.H. Mauch, K. Nagler, S. Schumacher, C. Goritz, E.C. Muller, A. Otto, and F.W. Pfrieger CNS synaptogenesis promoted by glia-derived cholesterol Science 294 2001 1354 1357
7. I. Bjorkhem, V. Leoni, and S. Meaney Genetic connections between neurological disorders and cholesterol metabolism J. Lipid Res. 51 2010 2489 2503
8. J.A. Porter, K.E. Young, and P.A. Beachy Cholesterol modification of hedgehog signaling proteins in animal development Science 274 1996 255 259
9. K.S. Ho, and M.P. Scott Sonic hedgehog in the nervous system: functions, modifications and mechanisms Curr. Opin. Neurobiol. 12 2002 57 63
10. P. Mannella, and R.D. Brinton Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action J. Neurosci. 26 2006 9439 9447
11. A. Nadal, M. Diaz, and M.A. Valverde The estrogen trinity: membrane, cytosolic, and nuclear effects News Physiol. Sci. 16 2001 251 255
12. R.C. Melcangi, L.M. Garcia-Segura, and A.G. Mensah-Nyagan Neuroactive steroids: state of the art and new perspectives Cell. Mol. Life Sci. 65 2008 777 797
13. I. Roglio, S. Giatti, M. Pesaresi, R. Bianchi, G. Cavaletti, G. Lauria, L.M. Garcia-Segura, and R.C. Melcangi Neuroactive steroids and peripheral neuropathy Brain Res. Rev. 57 2008 460 469
14. E.G. Lund, J.M. Guileyardo, and D.W. Russell cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain Proc. Natl. Acad. Sci. U. S. A. 96 1999 7238 7243
15. I. Bjorkhem Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain J. Intern. Med. 260 2006 493 508
16. S. Theofilopoulos, Y. Wang, S.S. Kitambi, P. Sacchetti, K.M. Sousa, K. Bodin, J. Kirk, C. Salto, M. Gustafsson, E.M. Toledo, K. Karu, J.A. Gustafsson, K.R. Steffensen, P. Ernfors, J. Sjovall, W.J. Griffiths, and E. Arenas Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis Nat. Chem. Biol. 9 2013 126 133
17. T.M. Jeitner, I. Voloshyna, and A.B. Reiss Oxysterol derivatives of cholesterol in neurodegenerative disorders Curr. Med. Chem. 18 2011 1515 1525
18. J.L. Goldstein, R.A. DeBose-Boyd, and M.S. Brown Protein sensors for membrane sterols Cell 124 2006 35 46
19. J.M. Lehmann, S.A. Kliewer, L.B. Moore, T.A. Smith-Oliver, B.B. Oliver, J.L. Su, S.S. Sundseth, D.A. Winegar, D.E. Blanchard, T.A. Spencer, and T.M. Willson Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway J. Biol. Chem. 272 1997 3137 3140
20. S. Andersson, N. Gustafsson, M. Warner, and J.A. Gustafsson Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice Proc. Natl. Acad. Sci. U. S. A. 102 2005 3857 3862
21. X. Fan, H.J. Kim, D. Bouton, M. Warner, and J.A. Gustafsson Expression of liver X receptor beta is essential for formation of superficial cortical layers and migration of later-born neurons Proc. Natl. Acad. Sci. U. S. A. 105 2008 13445 13450
22. L. Wang, G.U. Schuster, K. Hultenby, Q. Zhang, S. Andersson, and J.A. Gustafsson Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration Proc. Natl. Acad. Sci. U. S. A. 99 2002 13878 13883
23. M. Shafaati, M. Olin, A. Bavner, H. Pettersson, B. Rozell, S. Meaney, P. Parini, and I. Bjorkhem Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo J. Intern. Med. 270 2011 377 387
24. N. Noguchi, Y. Saito, and Y. Urano Diverse functions of 24(S)-hydroxycholesterol in the brain Biochem. Biophys. Res. Commun. 446 2014 692 696
25. S.M. Paul, J.J. Doherty, A.J. Robichaud, G.M. Belfort, B.Y. Chow, R.S. Hammond, D.C. Crawford, A.J. Linsenbardt, H.J. Shu, Y. Izumi, S.J. Mennerick, and C.F. Zorumski The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-d-aspartate receptors J. Neurosci. 33 2013 17290 17300
26. Y. Urano, S. Ochiai, and N. Noguchi Suppression of amyloid-beta production by 24S-hydroxycholesterol via inhibition of intracellular amyloid precursor protein trafficking FASEB J. 27 2013 4305 4315
27. E. Hudry, D. Van Dam, W. Kulik, P.P. De Deyn, F.S. Stet, O. Ahouansou, A. Benraiss, A. Delacourte, P. Bougneres, P. Aubourg, and N. Cartier Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease Mol. Ther. 18 2010 44 53
28. N. Bogdanovic, L. Bretillon, E.G. Lund, U. Diczfalusy, L. Lannfelt, B. Winblad, D.W. Russell, and I. Bjorkhem On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells Neurosci. Lett. 314 2001 45 48
29. G. Tian, Q. Kong, L. Lai, A. Ray-Chaudhury, and C.L. Lin Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease J. Neurochem. 113 2010 978 989
30. M. Ogundare, S. Theofilopoulos, A. Lockhart, L.J. Hall, E. Arenas, J. Sjovall, A.G. Brenton, Y. Wang, and W.J. Griffiths Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain? J. Biol. Chem. 285 2010 4666 4679
31. V. Keitel, B. Gorg, H.J. Bidmon, I. Zemtsova, L. Spomer, K. Zilles, and D. Haussinger The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain Glia 58 2010 1794 1805
32. M.H. Verheijen, N. Camargo, V. Verdier, K. Nadra, A.S. de Preux Charles, J.J. Medard, A. Luoma, M. Crowther, H. Inouye, H. Shimano, S. Chen, J.F. Brouwers, J.B. Helms, M.L. Feltri, L. Wrabetz, D. Kirschner, R. Chrast, and A.B. Smit SCAP is required for timely and proper myelin membrane synthesis Proc. Natl. Acad. Sci. U. S. A. 106 2009 21383 21388
33. M.H. Verheijen, R. Chrast, P. Burrola, and G. Lemke Local regulation of fat metabolism in peripheral nerves Genes Dev. 17 2003 2450 2464
34. R.W. Mitchell, and G.M. Hatch Fatty acid transport into the brain: of fatty acid fables and lipid tails Prostaglandins Leukot. Essent. Fat. Acids 85 2011 293 302
35. Y. Freund Levi, I. Vedin, T. Cederholm, H. Basun, G. Faxen Irving, M. Eriksdotter, E. Hjorth, M. Schultzberg, B. Vessby, L.O. Wahlund, N. Salem Jr., and J. Palmblad Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study J. Intern. Med. 275 2014 428 436
36. L.F. Barros Metabolic signaling by lactate in the brain Trends Neurosci. 36 2013 396 404
37. P. Schonfeld, and G. Reiser Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brain J. Cereb. Blood Flow Metab. 33 2013 1493 1499
38. S. Aggarwal, L. Yurlova, and M. Simons Central nervous system myelin: structure, synthesis and assembly Trends Cell Biol. 21 2011 585 593
39. W. Baron, and D. Hoekstra On the biogenesis of myelin membranes: sorting, trafficking and cell polarity FEBS Lett. 584 2010 1760 1770
40. D. Engblom, M. Ek, S. Saha, A. Ericsson-Dahlstrand, P.J. Jakobsson, and A. Blomqvist Prostaglandins as inflammatory messengers across the blood-brain barrier J. Mol. Med. (Berl) 80 2002 5 15
41. K.I. Strauss Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain Brain Behav. Immun. 22 2008 285 298
42. S. Palumbo, and F. Bosetti Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: role of cyclooxygenase-2 Prostaglandins Leukot. Essent. Fat. Acids 89 2013 273 278
43. C.B. Saper, A.A. Romanovsky, and T.E. Scammell Neural circuitry engaged by prostaglandins during the sickness syndrome Nat. Neurosci. 15 2012 1088 1095
44. W. Ma, B. St-Jacques, and P.C. Duarte Targeting pain mediators induced by injured nerve-derived COX2 and PGE2 to treat neuropathic pain Expert Opin. Ther. Targets 16 2012 527 540
45. C.A. Rouzer, and L.J. Marnett Non-redundant functions of cyclooxygenases: oxygenation of endocannabinoids J. Biol. Chem. 283 2008 8065 8069
46. D.J. Hermanson, N.D. Hartley, J. Gamble-George, N. Brown, B.C. Shonesy, P.J. Kingsley, R.J. Colbran, J. Reese, L.J. Marnett, and S. Patel Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation Nat. Neurosci. 16 2013 1291 1298
47. K. Yoshikawa, S. Takei, S. Hasegawa-Ishii, Y. Chiba, A. Furukawa, N. Kawamura, M. Hosokawa, D.F. Woodward, K. Watanabe, and A. Shimada Preferential localization of prostamide/prostaglandin F synthase in myelin sheaths of the central nervous system Brain Res. 1367 2011 22 32
48. N.G. Bazan Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection Curr. Opin. Clin. Nutr. Metab. Care 10 2007 136 141
49. R.R. Ji, Z.Z. Xu, G. Strichartz, and C.N. Serhan Emerging roles of resolvins in the resolution of inflammation and pain Trends Neurosci. 34 2011 599 609
50. J.J. Hulce, A.B. Cognetta, M.J. Niphakis, S.E. Tully, and B.F. Cravatt Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells Nat. Methods 10 2013 259 264
51. B.U. Fitzky, F.F. Moebius, H. Asaoka, H. Waage-Baudet, L. Xu, G. Xu, N. Maeda, K. Kluckman, S. Hiller, H. Yu, A.K. Batta, S. Shefer, T. Chen, G. Salen, K. Sulik, R.D. Simoni, G.C. Ness, H. Glossmann, S.B. Patel, and G.S. Tint 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome J. Clin. Invest. 108 2001 905 915
52. S.S. Chirala, H. Chang, M. Matzuk, L. Abu-Elheiga, J. Mao, K. Mahon, M. Finegold, and S.J. Wakil Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero Proc. Natl. Acad. Sci. U. S. A. 100 2003 6358 6363
53. R. Tozawa, S. Ishibashi, J. Osuga, H. Yagyu, T. Oka, Z. Chen, K. Ohashi, S. Perrey, F. Shionoiri, N. Yahagi, K. Harada, T. Gotoda, Y. Yazaki, and N. Yamada Embryonic lethality and defective neural tube closure in mice lacking squalene synthase J. Biol. Chem. 274 1999 30843 30848
54. M.V. Chakravarthy, Y. Zhu, L. Yin, T. Coleman, K.L. Pappan, C.A. Marshall, M.L. McDaniel, and C.F. Semenkovich Inactivation of hypothalamic FAS protects mice from diet-induced obesity and inflammation J. Lipid Res. 50 2009 630 640
55. M.V. Chakravarthy, Y. Zhu, M. Lopez, L. Yin, D.F. Wozniak, T. Coleman, Z. Hu, M. Wolfgang, A. Vidal-Puig, M.D. Lane, and C.F. Semenkovich Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis J. Clin. Invest. 117 2007 2539 2552
56. M.V. Chakravarthy, I.J. Lodhi, L. Yin, R.R. Malapaka, H.E. Xu, J. Turk, and C.F. Semenkovich Identification of a physiologically relevant endogenous ligand for PPARalpha in liver Cell 138 2009 476 488
57. A. Wechsler, A. Brafman, M. Shafir, M. Heverin, H. Gottlieb, G. Damari, S. Gozlan-Kelner, I. Spivak, O. Moshkin, E. Fridman, Y. Becker, R. Skaliter, P. Einat, A. Faerman, I. Bjorkhem, and E. Feinstein Generation of viable cholesterol-free mice Science 302 2003 2087
58. G. Saher, S. Quintes, W. Mobius, M.C. Wehr, E.M. Kramer-Albers, B. Brugger, and K.A. Nave Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction J. Neurosci. 29 2009 6094 6104
59. R. Suzuki, H.A. Ferris, M.J. Chee, E. Maratos-Flier, and C.R. Kahn Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function PLoS Biol. 11 2013 e1001532
60. J.J. Repa, G. Liang, J. Ou, Y. Bashmakov, J.M. Lobaccaro, I. Shimomura, B. Shan, M.S. Brown, J.L. Goldstein, and D.J. Mangelsdorf Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta Genes Dev. 14 2000 2819 2830
61. J. Makoukji, G. Shackleford, D. Meffre, J. Grenier, P. Liere, J.M. Lobaccaro, M. Schumacher, and C. Massaad Interplay between LXR and Wnt/beta-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols J. Neurosci. 31 2011 9620 9629
62. R. Chrast, G. Saher, K.A. Nave, and M.H. Verheijen Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models J. Lipid Res. 52 2011 419 434
63. D.C. German, E.M. Quintero, C.L. Liang, B. Ng, S. Punia, C. Xie, and J.M. Dietschy Selective neurodegeneration, without neurofibrillary tangles, in a mouse model of Niemann-Pick C disease J. Comp. Neurol. 433 2001 415 425
64. D.E. Sleat, J.A. Wiseman, M. El-Banna, S.M. Price, L. Verot, M.M. Shen, G.S. Tint, M.T. Vanier, S.U. Walkley, and P. Lobel Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport Proc. Natl. Acad. Sci. U. S. A. 101 2004 5886 5891
65. T. Yu, and A.P. Lieberman Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelin PLoS Genet. 9 2013 e1003462
66. R.E. Pitas, J.K. Boyles, S.H. Lee, D. Hui, and K.H. Weisgraber Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain J. Biol. Chem. 262 1987 14352 14360
67. V. Hirsch-Reinshagen, S. Zhou, B.L. Burgess, L. Bernier, S.A. McIsaac, J.Y. Chan, G.H. Tansley, J.S. Cohn, M.R. Hayden, and C.L. Wellington Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain J. Biol. Chem. 279 2004 41197 41207
68. J.M. Karasinska, F. Rinninger, D. Lutjohann, P. Ruddle, S. Franciosi, J.K. Kruit, R.R. Singaraja, V. Hirsch-Reinshagen, J. Fan, L.R. Brunham, N. Bissada, R. Ramakrishnan, C.L. Wellington, J.S. Parks, and M.R. Hayden Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function J. Neurosci. 29 2009 3579 3589
69. V. Papadopoulos, and W.L. Miller Role of mitochondria in steroidogenesis Best Pract. Res. Clin. Endocrinol. Metab. 26 2012 771 790
70. V. Papadopoulos, H. Amri, N. Boujrad, C. Cascio, M. Culty, M. Garnier, M. Hardwick, H. Li, B. Vidic, A.S. Brown, J.L. Reversa, J.M. Bernassau, and K. Drieu Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis Steroids 62 1997 21 28
71. K. Morohaku, S.H. Pelton, D.J. Daugherty, W.R. Butler, W. Deng, and V. Selvaraj Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis Endocrinology 155 2014 89 97
72. K.M. Caron, S.C. Soo, W.C. Wetsel, D.M. Stocco, B.J. Clark, and K.L. Parker Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia Proc. Natl. Acad. Sci. U. S. A. 94 1997 11540 11545
73. D.S. Lala, D.A. Rice, and K.L. Parker Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I Mol. Endocrinol. 6 1992 1249 1258
74. K. Morohashi, S. Honda, Y. Inomata, H. Handa, and T. Omura A common trans-acting factor, Ad4-binding protein, to the promoters of steroidogenic P-450 s J. Biol. Chem. 267 1992 17913 17919
75. L. Zhao, K.W. Kim, Y. Ikeda, K.K. Anderson, L. Beck, S. Chase, S.A. Tobet, and K.L. Parker Central nervous system-specific knockout of steroidogenic factor 1 results in increased anxiety-like behavior Mol. Endocrinol. 22 2008 1403 1415
76. T.J. Kotti, D.M. Ramirez, B.E. Pfeiffer, K.M. Huber, and D.W. Russell Brain cholesterol turnover required for geranylgeraniol production and learning in mice Proc. Natl. Acad. Sci. U. S. A. 103 2006 3869 3874
77. K.A. Nave, C. Lai, F.E. Bloom, and R.J. Milner Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin Proc. Natl. Acad. Sci. U. S. A. 84 1987 5665 5669
78. M. Klugmann, M.H. Schwab, A. Puhlhofer, A. Schneider, F. Zimmermann, I.R. Griffiths, and K.A. Nave Assembly of CNS myelin in the absence of proteolipid protein Neuron 18 1997 59 70
79. H.B. Werner, E.M. Kramer-Albers, N. Strenzke, G. Saher, S. Tenzer, Y. Ohno-Iwashita, P. De Monasterio-Schrader, W. Mobius, T. Moser, I.R. Griffiths, and K.A. Nave A critical role for the cholesterol-associated proteolipids PLP and M6B in myelination of the central nervous system Glia 61 2013 567 586
80. M. Sereda, I. Griffiths, A. Puhlhofer, H. Stewart, M.J. Rossner, F. Zimmerman, J.P. Magyar, A. Schneider, E. Hund, H.M. Meinck, U. Suter, and K.A. Nave A transgenic rat model of Charcot-Marie-Tooth disease Neuron 16 1996 1049 1060
81. K. Adlkofer, R. Martini, A. Aguzzi, J. Zielasek, K.V. Toyka, and U. Suter Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice Nat. Genet. 11 1995 274 280
82. R. Martini, J. Zielasek, K.V. Toyka, K.P. Giese, and M. Schachner Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies Nat. Genet. 11 1995 281 286
83. L. Wrabetz, M.L. Feltri, A. Quattrini, D. Imperiale, S. Previtali, M. D'Antonio, R. Martini, X. Yin, B.D. Trapp, L. Zhou, S.Y. Chiu, and A. Messing P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves J. Cell Biol. 148 2000 1021 1034
84. B.D. Trapp, M. Dubois-Dalcq, and R.H. Quarles Ultrastructural localization of P2 protein in actively myelinating rat Schwann cells J. Neurochem. 43 1984 944 948
85. S. Suresh, C. Wang, R. Nanekar, P. Kursula, and J.M. Edwardson Myelin basic protein and myelin protein 2 act synergistically to cause stacking of lipid bilayers Biochemistry 49 2010 3456 3463
86. J. Zenker, M. Stettner, S. Ruskamo, E. Domenech-Estevez, H. Baloui, J.J. Medard, M.H. Verheijen, J.F. Brouwers, P. Kursula, B.C. Kieseier, and R. Chrast A role of peripheral myelin protein 2 in lipid homeostasis of myelinating Schwann cells Glia 62 9 2014 1502 1512
87. C.A. Wassif, P. Zhu, L. Kratz, P.A. Krakowiak, K.P. Battaile, F.F. Weight, A. Grinberg, R.D. Steiner, N.A. Nwokoro, R.I. Kelley, R.R. Stewart, and F.D. Porter Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome Hum. Mol. Genet. 10 2001 555 564
88. L.S. Correa-Cerro, C.A. Wassif, L. Kratz, G.F. Miller, J.P. Munasinghe, A. Grinberg, S.J. Fliesler, and F.D. Porter Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy Hum. Mol. Genet. 15 2006 839 851
89. Y. Tang, H. Li, and J.P. Liu Niemann-Pick disease type C: from molecule to clinic Clin. Exp. Pharmacol. Physiol. 37 2010 132 140
90. M.E. Lopez, and M.P. Scott Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C Dis. Model. Mech. 6 2013 1089 1100
91. R.A. Maue, R.W. Burgess, B. Wang, C.M. Wooley, K.L. Seburn, M.T. Vanier, M.A. Rogers, C.C. Chang, T.Y. Chang, B.T. Harris, D.J. Graber, C.A. Penatti, D.M. Porter, B.S. Szwergold, L.P. Henderson, J.W. Totenhagen, T.P. Trouard, I.A. Borbon, and R.P. Erickson A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations Hum. Mol. Genet. 21 2012 730 750
92. A. Brooks-Wilson, M. Marcil, S.M. Clee, L.H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J.A. Collins, H.O. Molhuizen, O. Loubser, B.F. Ouelette, K. Fichter, K.J. Ashbourne-Excoffon, C.W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J.J. Kastelein, J. Genest Jr., and M.R. Hayden Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency Nat. Genet. 22 1999 336 345
93. M. Marcil, A. Brooks-Wilson, S.M. Clee, K. Roomp, L.H. Zhang, L. Yu, J.A. Collins, M. van Dam, H.O. Molhuizen, O. Loubster, B.F. Ouellette, C.W. Sensen, K. Fichter, S. Mott, M. Denis, B. Boucher, S. Pimstone, J. Genest Jr., J.J. Kastelein, and M.R. Hayden Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux Lancet 354 1999 1341 1346
94. A.T. Remaley, S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K.M. Peterson, C. Koch, I. Arnould, C. Prades, N. Duverger, H. Funke, G. Assman, M. Dinger, M. Dean, G. Chimini, S. Santamarina-Fojo, D.S. Fredrickson, P. Denefle, and H.B. Brewer Jr. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred Proc. Natl. Acad. Sci. U. S. A. 96 1999 12685 12690
95. S. Rust, M. Rosier, H. Funke, J. Real, Z. Amoura, J.C. Piette, J.F. Deleuze, H.B. Brewer, N. Duverger, P. Denefle, and G. Assmann Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 Nat. Genet. 22 1999 352 355
96. v.E.A. G. Assmann, H.B. Brewer Jr. Familial high density lipoprotein deficiency: Tangier disease 1995 McGraw-Hill New York
97. T.A. Christiansen-Weber, J.R. Voland, Y. Wu, K. Ngo, B.L. Roland, S. Nguyen, P.A. Peterson, and W.P. Fung-Leung Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency Am. J. Pathol. 157 2000 1017 1029
98. J.E. Vance Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases Dis. Model. Mech. 5 2012 746 755
99. G. Cermenati, F. Abbiati, S. Cermenati, E. Brioschi, A. Volonterio, G. Cavaletti, E. Saez, E. De Fabiani, M. Crestani, L.M. Garcia-Segura, R.C. Melcangi, D. Caruso, and N. Mitro Diabetes-induced myelin abnormalities are associated with an altered lipid pattern: protective effects of LXR activation J. Lipid Res. 53 2012 300 310
100. S. Gillette-Guyonnet, M. Secher, and B. Vellas Nutrition and neurodegeneration: epidemiological evidence and challenges for future research Br. J. Clin. Pharmacol. 75 2013 738 755
101. R.C. Melcangi, I.T. Cavarretta, M. Ballabio, E. Leonelli, A. Schenone, I. Azcoitia, L. Miguel Garcia-Segura, and V. Magnaghi Peripheral nerves: a target for the action of neuroactive steroids Brain Res. Brain Res. Rev. 48 2005 328 338
102. R.C. Melcangi, and L.M. Garcia-Segura Therapeutic approaches to peripheral neuropathy based on neuroactive steroids Expert. Rev. Neurother. 6 2006 1121 1125
103. D. Caruso, S. Scurati, O. Maschi, L. De Angelis, I. Roglio, S. Giatti, L.M. Garcia-Segura, and R.C. Melcangi Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes Neurochem. Int. 52 2008 560 568
104. M. Pesaresi, O. Maschi, S. Giatti, L.M. Garcia-Segura, D. Caruso, and R.C. Melcangi Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats Horm. Behav. 57 2010 46 55
105. R.C. Melcangi, S. Giatti, D. Calabrese, M. Pesaresi, G. Cermenati, N. Mitro, B. Viviani, L.M. Garcia-Segura, and D. Caruso Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions Prog. Neurobiol. 113 2014 56 69
106. M.A. Yorek, L.J. Coppey, J.S. Gellett, E.P. Davidson, X. Bing, D.D. Lund, and J.S. Dillon Effect of treatment of diabetic rats with dehydroepiandrosterone on vascular and neural function Am. J. Physiol. Endocrinol. Metab. 283 2002 E1067 E1075
107. R.C. Melcangi, and A.G. Mensah-Nyagan Neurosteroids: measurement and pathophysiologic relevance Neurochem. Int. 52 2008 503 505
108. S. Giatti, M. Pesaresi, G. Cavaletti, R. Bianchi, V. Carozzi, R. Lombardi, O. Maschi, G. Lauria, L.M. Garcia-Segura, D. Caruso, and R.C. Melcangi Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy Neuroscience 164 2009 520 529
109. G. Cermenati, S. Giatti, G. Cavaletti, R. Bianchi, O. Maschi, M. Pesaresi, F. Abbiati, A. Volonterio, E. Saez, D. Caruso, R.C. Melcangi, and N. Mitro Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy J. Neurosci. 30 2010 11896 11901
110. A.F. Macedo, F.C. Taylor, J.P. Casas, A. Adler, D. Prieto-Merino, and S. Ebrahim Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis BMC Med. 12 2014 51
111. J. Folch H. Waelsch, The Biochemistry of the Developing Nervous System 1955 Academic Press New York 21